Thermo Fisher Scientific (TMO) Deferred Taxes (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Deferred Taxes for 18 consecutive years, with -$258.0 million the latest figure, recorded in Q1 2026.

• Deferred Taxes for Q1 2026 came in at -$258.0 million, up 7.53% year-over-year; the trailing twelve-month figure through Mar 2026 was -$618.0 million (up 64.5% YoY), and the FY2025 annual result was -$639.0 million, up 47.15% from the prior year.
• Deferred Taxes was -$258.0 million for Q1 2026 at Thermo Fisher Scientific, down from $89.0 million in the prior quarter.
• Over five years, Deferred Taxes peaked at $339.0 million in Q2 2022 and troughed at -$1.9 billion in Q4 2023.
• Average Deferred Taxes over 5 years is -$141.8 million, with a median of $89.0 million recorded in 2025.
• Year-over-year, Deferred Taxes soared 1512.5% in 2022 and tumbled 1551.88% in 2023.
• Over 5 years, Deferred Taxes stood at $133.0 million in 2022, then sank by 1551.88% to -$1.9 billion in 2023, then soared by 89.54% to -$202.0 million in 2024, then soared by 144.06% to $89.0 million in 2025, then tumbled by 389.89% to -$258.0 million in 2026.
• Per Business Quant data, the three most recent Deferred Taxes figures were -$258.0 million in Q1 2026, $89.0 million in Q4 2025, and -$127.0 million in Q3 2025.